TCGX Acquisition Corp. raises $86.25M in Nasdaq IPO

TCGX Acquisition Corp. (NASDAQ: TCGX) completed its initial public offering of 8,625,000 Class A ordinary shares at $10.00 per share, raising $86.25M in total proceeds, according to a press release from the company.

The offering included 1,125,000 shares issued through the full exercise of the underwriter's over-allotment option. The shares began trading on the Nasdaq Capital Market on August 5, 2026.

The company is a special purpose acquisition company, or SPAC, sponsored by TCGX Sponsor, LLC, an affiliate of TCG Crossover Management, LLC. It intends to focus its acquisition search on the healthcare and healthcare-related industries, particularly in the life sciences and medical technology sectors, though it may pursue targets in any industry or geography.

Jefferies acted as the sole book-running manager for the offering. The SEC declared the registration statement effective on August 4, 2026.

You May Also Be Interested In

• ZincFive and Spark I file draft S-4 for planned merger
• bioAffinity Technologies prices $4M private placement on Nasdaq
• MapLight Therapeutics raises $150M in private placement